Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHYR.L Regulatory News (HYR)

  • There is currently no data for HYR

Board Changes

4 Dec 2015 07:00

RNS Number : 9729H
HydroDec Group plc
04 December 2015
 

4 December 2015

 

Hydrodec Group plc

("Hydrodec" or the "Company")

 

Board changes

 

Hydrodec Group plc (AIM: HYR), the cleantech industrial oil re-refining group, announces that Ian Smale, Chief Executive, will step down as Chief Executive of the Company by mutual agreement today. Since joining in 2012, Ian has led the Company's expanded footprint and been fundamental to the development of the Company's strategy. The Board is grateful to him for his leadership and commitment and wishes him well for the future.

 

The Board is pleased to announce the appointment of the Company's current Chief Financial Officer, Chris Ellis, as Acting Chief Executive with immediate effect. Chris' appointment is for an initial term of up to 6 months and Chris will, in the near term, undertake the roles of both Acting Chief Executive and Chief Financial Officer. Chris is a qualified chartered accountant and has more than 20 years' board level finance and management experience of running a range of large, complex international businesses as well as small and medium sized ventures, including a significant period within GE Capital. The Board believes no immediate replacement for the role of Chief Financial Officer will be required as Chris will continue to work with the Board and his finance team to ensure processes are in place to ensure his ongoing financial role is appropriately supported. The Company intends to commence an appropriate process to make an executive appointment to the Board in due course as necessary.

 

The Company also announces today that Caroline Brown will assume the role of Senior Independent Director with effect from today, having joined the Company as an Independent Non-Executive Director and Chair of the Audit Committee on 23 September 2015. Caroline will support Chris in ensuring the financial function is appropriately managed and monitored.

 

Chairman, Lord Moynihan stated: "The ongoing ramp-up to full operations in Canton coupled with the recently announced long-term funding are a platform for a strong focus on operational delivery and the next phase in the Company's development. The Board is grateful for Ian's leadership through the recent difficulties which we believe are now behind us.

2016 will be an important year for Hydrodec. With our Canton plant in production, the focus is on production and sale of transformer oil into the U.S. market as this represents the key generator of cash in the Company portfolio. We remain confident that the rebuilt and expanded plant has a unique market proposition and is well placed in 2016 to leverage the production of the highest quality transformer oil produced in the US. Our objective remains to grow a profitable Company and deliver value for shareholders through integrated used oil re-refining solutions based on market-leading proprietary technology.

The whole Board is focused on execution, delivering improved operational performance and efficiencies and driving the Company to profitability and this is reinforced by the appointment of Chris Ellis as Acting Chief Executive."

For further information please contact:

 

Hydrodec Group plc

 

020 3300 1643

 

Lord Moynihan, Chairman

Chris Ellis, Acting Chief Executive

James Hodges, General Counsel and Company Secretary

 

 

 

Canaccord Genuity (Nominated Adviser and Broker)

 

020 7523 8000

 

Guy Marks

Henry Fitzgerald-O'Connor

 

 

 

Vigo Communications (PR adviser to Hydrodec)

 

020 7016 9570

Patrick d'Ancona

Chris McMahon

 

 

 

Notes to Editors:

Hydrodec's technology is a proven, highly efficient, oil re-refining and chemical process initially targeted at the multi-billion US$ market for transformer oil used by the world's electricity industry. Spent oil is currently processed at two commercial plants with distinct competitive advantage delivered through very high recoveries (near 100%), producing 'as new' high quality oils at competitive cost and without environmentally harmful emissions. The process also completely eliminates PCBs, a toxic additive banned under international regulations. Hydrodec's plants are located at Canton, Ohio, US and Young, New South Wales, Australia. In 2013, Hydrodec acquired the business and assets of OSS Group, the UK's largest collector, consolidator and processor of used lubricant oil and seller of processed fuel oil, with a national network of oil storage and transfer stations. Used oil is converted into processed fuel oil at OSS's plant at Stourport and principally sold on to the UK quarry and power industry. In April 2015, Hydrodec further acquired the business and assets of Eco Oil, a leading UK waste oil collector and supplier of recycled industrial fuel oil into the power and road stone industries. It is also one of four significant providers of waste management services to the marine industry in the UK, specifically oily-water slops or marine pollutant (MARPOL). In line with our stated intention to develop a base oil re-refinery in the UK, we have an exclusive licence agreement with California-based Chemical Engineering Partners (CEP) to develop the CEP wiped-film evaporation and hydrogenation technology in the UK as well as the basic engineering for a 75 million litre per annum capacity base oil re-refinery.

Hydrodec's shares are listed on the AIM Market of the London Stock Exchange. For further information, please visit www.hydrodec.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUOUKRVRAURAA
Date   Source Headline
8th Oct 20189:00 amRNSPrice Monitoring Extension
8th Oct 20187:00 amRNSProposed placing to raise a minimum of £10m
28th Sep 20183:45 pmRNSBusiness Review Update
10th Sep 20187:00 amRNSHalf-year Report
22nd Aug 20187:00 amRNSRe-refining technology patent extended to Europe
15th Aug 20183:27 pmRNSHolding(s) in Company
3rd Aug 20187:00 amRNSTrading Update
27th Jun 201812:10 pmRNSResult of AGM
4th Jun 20182:32 pmRNS2017 Annual Report and Accounts and Notice of AGM
31st May 20181:39 pmRNSDirector/PDMR Shareholding
31st May 201812:05 pmRNSFinal Results
25th May 20187:00 amRNSChange of Adviser
2nd May 20187:00 amRNSQ1 Trading Update
4th Apr 20187:00 amRNSDirectorate Change
29th Jan 20187:00 amRNSPre-close Trading Update
28th Dec 20177:00 amRNSExtension of working capital facilities
16th Nov 20172:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20175:16 pmRNSHolding(s) in Company
31st Oct 201711:38 amRNSHolding(s) in Company
27th Oct 20177:00 amRNSGrant of options
26th Oct 20177:00 amRNSQ3 Trading Update
5th Oct 20177:00 amRNSHolding(s) in Company
25th Sep 20177:00 amRNSHalf Yearly Report
18th Sep 20177:00 amRNSNew patent
12th Jul 20177:00 amRNSCarbon Credit Service Agreement
27th Jun 201711:00 amRNSResult of AGM
27th Jun 20177:00 amRNSAGM Statement
2nd Jun 20179:32 amRNS2016 Annual Report and Accounts and Notice of AGM
12th May 20177:00 amRNSFinal Results
8th May 20177:00 amRNSInitial Sale of Carbon Credits
12th Apr 20177:00 amRNSQ1 2017 Trading Update
11th Apr 20174:11 pmRNSHolding(s) in Company
14th Feb 201710:52 amRNSHolding(s) in Company
14th Feb 201710:48 amRNSHolding(s) in Company
30th Jan 20177:00 amRNSPre-close Trading Update
24th Jan 201711:45 amRNSHolding(s) in Company
12th Dec 20167:00 amRNSTrading Update
20th Oct 201611:30 amRNSHolding(s) in Company
17th Oct 20167:00 amRNSAdditional Investment in Hydrodec of North America
11th Oct 201611:20 amRNSHolding(s) in Company
3rd Oct 20161:30 pmRNSChange of Registered Office
16th Sep 20167:00 amRNSHalf Yearly Report
8th Sep 20167:00 amRNSCarbon Credit Project Approval
18th Aug 20167:00 amRNSContract Win
21st Jul 20165:00 pmRNSHolding(s) in Company
20th Jul 20167:00 amRNSTrading Update
24th Jun 20164:58 pmRNSDirector/PDMR Shareholding
14th Jun 201612:50 pmRNSHolding(s) in Company
10th Jun 201612:53 pmRNSDirector's shareholding
9th Jun 20165:35 pmRNSDirectors' shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.